
    
      Objective(s):

      To determine the feasibility of CS mapping with NavX during Biventricular Implantable
      Cardioverter Defibrillator (BiV ICD) implantation.

      Inclusion Criteria:

        -  Subject is between the age of 18 and 75 years

        -  Subject is willing and able to sign a study specific informed consent

        -  Subject is able to fulfill study requirements

        -  Meet the conventional criteria for implant of a BiV ICD, including; LVEF of ≤35%, QRS ≥
           120 ms and NYHA III-IV

        -  Have persistent CHF symptoms despite contemporary CHF medical therapy

        -  Stable and optimal medical therapy (stability is no changes in past 3 months).

        -  Documented history of ischemic or non-ischemic cardiomyopathy.

      Exclusion Criteria:

        -  Have any standard device exclusions including tricuspid valve prosthesis/ replacement.

        -  Have a positive urine or serum pregnancy test (if female and of childbearing potential)

        -  Be currently participating in an IDE or IND study.
    
  